Answers are grounded in this paper and cite their sources.
Recombinant interferon beta is commonly used in the treatment of multiple sclerosis. In this letter, cases of thrombotic microangiopathy that were reported in South Scotland appear to be related to the use of a particular preparation of interferon beta.
No takes yet. Share an insight, caveat, or question.
Hunt et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: